Stopping, continuing, or restarting immunomodulators and biologics when an infection or malignancy develops.

Stopping, continuing, or restarting immunomodulators and biologics when an infection or malignancy develops.

Item
http://www.wikidata.org/entity/Q38197891
Use of biologics and chemotherapy in patients with inflammatory bowel diseases and cancerIBD LIVE Case Series-Case 2: Previous Cancer in a Patient with Crohn's Disease: Is It Appropriate to Use Biologics and Immunosuppressants for IBD Treatment?Does a personal or family history of malignancy preclude the use of immunomodulators and biologics in IBD.European Crohn's and Colitis Organisation Topical Review on IBD in the Elderly.Understanding the Cautions and Contraindications of Immunomodulator and Biologic Therapies for Use in Inflammatory Bowel Disease.Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases 2009-2014.Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.
P2860

Stopping, continuing, or restarting immunomodulators and biologics when an infection or malignancy develops.

Item
http://www.wikidata.org/entity/Q38197891
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Stopping, continuing, or resta ...... ection or malignancy develops.
@en
type
label
Stopping, continuing, or resta ...... ection or malignancy develops.
@en
prefLabel
Stopping, continuing, or resta ...... ection or malignancy develops.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Stopping, continuing, or resta ...... ection or malignancy develops.
@en
P2093
P2860
P304
P31
P356
10.1097/MIB.0000000000000002
P433
P478
P577
P698